Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-12-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm has not commenced any operations. The firm has not generated any revenues.
Oaktree Acquisition III Life Sciences Corp 的关键财务报表是什么?
根据最新的财务报表(Form-10K),Oaktree Acquisition III Life Sciences Corp 的总资产为 $0,净损失为 $0
OACC 的关键财务比率是什么?
Oaktree Acquisition III Life Sciences Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Oaktree Acquisition III Life Sciences Corp 的收入按细分市场或地理位置如何划分?
Oaktree Acquisition III Life Sciences Corp 最大收入来源是 Work Truck Solutions,在最近的收益报告中收入为 312,494,000。就地区而言, North America 是 Oaktree Acquisition III Life Sciences Corp 的主要市场,收入为 568,504,000。
Oaktree Acquisition III Life Sciences Corp 是否盈利?
不,根据最新的财务报表,Oaktree Acquisition III Life Sciences Corp 的净损失为 $0
Oaktree Acquisition III Life Sciences Corp 有负债吗?
不,Oaktree Acquisition III Life Sciences Corp 的负债为 0
Oaktree Acquisition III Life Sciences Corp 的流通股有多少?
Oaktree Acquisition III Life Sciences Corp 的总流通股为 0